Attached files

file filename
10-K - 10-K - MYRIAD GENETICS INCmygn-10k_20170630.htm
EX-31.2 - EX-31.2 - MYRIAD GENETICS INCmygn-ex312_14.htm
EX-31.1 - EX-31.1 - MYRIAD GENETICS INCmygn-ex311_13.htm
EX-23.1 - EX-23.1 - MYRIAD GENETICS INCmygn-ex231_15.htm
EX-21.1 - EX-21.1 - MYRIAD GENETICS INCmygn-ex211_16.htm

 

Exhibit 32

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report on Form 10-K for the year ended June 30, 2017 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date:  August 9, 2017

 

Date:  August 9, 2017

 

 

 

/s/ Mark C. Capone

 

/s/ R. Bryan Riggsbee

 

 

 

Mark C. Capone  

 

R. Bryan Riggsbee

President and Chief Executive Officer

 

Chief Financial Officer